ProfileJobs

Globus Medical

HealthManufacturing & Industrialmedical devicesmedtech

Globus Medical, Inc. is a medical device company focused on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company's products are classified into two categories: Innovative Fusion and Disruptive Technologies. The Innovative Fusion products are used in cervical, thoracolumbar, sacral, and interbody, corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions.

Revenue(Q1, 2017)
$155.8 M
Market capitalization(2017-08-17)
$3 B
Company Growth (employees)
Type
Public
HQ
Eagleville, US
Founded
2003
Size (employees)
1,400 (est)+17%
Website
globusmedical.com
Globus Medical was founded in 2003 and is headquartered in Eagleville, US

Globus Medical Office Locations

Globus Medical has an office in Eagleville
Eagleville, US (HQ)
2560 General Armistead Ave

Globus Medical Data and Metrics

Globus Medical Financial Metrics

Globus Medical's revenue was reported to be $155.8 m in Q1, 2017
USD

Revenue (Q1, 2017)

155.8 m

Gross profit (Q1, 2017)

120.2 m

Gross profit margin (Q1, 2017), %

77%

Net income (Q1, 2017)

28.7 m

EBIT (Q1, 2017)

40.3 m

Market capitalization (17-Aug-2017)

3 b

Cash (31-Mar-2017)

182.4 m
Globus Medical's current market capitalization is $3 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

434.5 m474.4 m544.8 m564 m

Revenue growth, %

9%15%4%

Cost of goods sold

132.8 m134.7 m

Gross profit

334.1 m363.5 m412 m429.3 m

Gross profit Margin, %

77%77%76%76%

R&D expense

44.5 m

General and administrative expense

222.2 m

Operating expense total

232.4 m225.2 m239.7 m275.1 m

EBIT

101.7 m138.4 m172.2 m154.1 m

EBIT margin, %

23%29%32%27%

Pre tax profit

172.8 m157.3 m

Income tax expense

60 m52.9 m

Net Income

68.6 m92.5 m112.8 m104.3 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

133.6 m137 m139.3 m137.5 m135.7 m155.8 m

Cost of goods sold

32.6 m33.1 m31.6 m32.9 m31.5 m35.6 m

Gross profit

101 m103.9 m107.6 m104.6 m104.2 m120.2 m

Gross profit Margin, %

76%76%77%76%77%77%

R&D expense

9.1 m9.4 m10.2 m11.3 m10.3 m10.7 m

General and administrative expense

54.5 m53.8 m54.6 m52.4 m54.2 m67.1 m

Operating expense total

63.6 m63.2 m64.8 m63.7 m64.5 m77.7 m

EBIT

37 m40.7 m42.9 m37.9 m37.7 m40.3 m

EBIT margin, %

28%30%31%28%28%26%

Pre tax profit

37.5 m40.9 m43.6 m38.3 m38.9 m42.4 m

Income tax expense

13.4 m14.4 m15.6 m12.5 m12.6 m13.7 m

Net Income

41.8 m64.8 m24.6 m48.7 m75.2 m28 m53.8 m80 m28.7 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

90 m82.3 m60.2 m132.6 m

Inventories

70.4 m90.9 m105.3 m112.7 m

Current Assets

416.8 m470 m544.8 m513.8 m

PP&E

64.2 m

Goodwill

18.4 m53.2 m92 m105.9 m

Total Assets

566.3 m703.5 m834.1 m927.6 m

Accounts Payable

10.1 m15.9 m16 m17.5 m

Current Liabilities

67.9 m89.4 m82.7 m79.9 m

Total Liabilities

95.6 m

Common Stock

71 k71 k72 k

Additional Paid-in Capital

154 m175.2 m192.6 m211.7 m

Retained Earnings

319.3 m411.8 m524.6 m628.9 m

Total Equity

472.4 m585.5 m715.3 m832.1 m

Financial Leverage

1.2 x1.2 x1.2 x1.1 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

136.5 m169.4 m75 m41.6 m50.5 m81.3 m95.3 m90.2 m182.4 m

Inventories

76.4 m77.4 m98.9 m101 m105.7 m105.1 m104.4 m115.6 m113 m

Current Assets

467.1 m484.8 m455.7 m454.8 m506.3 m515.5 m535.4 m478.2 m540.9 m

Goodwill

18.4 m18.4 m93.6 m93.6 m92 m92 m92 m110.3 m106.2 m

Total Assets

618 m646.4 m744.1 m764.7 m800.7 m840 m869.5 m901.7 m960.4 m

Accounts Payable

8.8 m9.7 m19.4 m18.3 m16.4 m12.1 m11.6 m13.9 m17 m

Current Liabilities

66 m72.8 m93.3 m91.7 m94.4 m72.3 m70.3 m65.8 m75.4 m

Common Stock

71 k71 k71 k71 k72 k72 k72 k

Additional Paid-in Capital

168 m170.9 m179.5 m184.2 m188.6 m197.9 m202.8 m207.2 m217.3 m

Retained Earnings

361.1 m384.1 m436.4 m460.5 m487 m552.6 m578.4 m604.6 m657.6 m

Total Equity

528.3 m553.8 m614.2 m643.1 m673.9 m748.9 m779.5 m810.1 m868.9 m

Financial Leverage

1.2 x1.2 x1.2 x1.2 x1.2 x1.1 x1.1 x1.1 x1.1 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

68.6 m92.5 m112.8 m104.3 m

Depreciation and Amortization

19.4 m21.8 m24.1 m3.5 m

Accounts Receivable

(9.6 m)(13 m)(4.2 m)(4.7 m)

Inventories

(17 m)(18 m)(19 m)(10.5 m)

Accounts Payable

1.8 m4.6 m(3.8 m)(23 k)

Cash From Operating Activities

93.5 m79.2 m122 m171.9 m

Purchases of PP&E

(23.7 m)(24.8 m)(50.8 m)(40.9 m)

Cash From Investing Activities

(227.2 m)(100 m)(150.6 m)(99.6 m)

Cash From Financing Activities

11 m12.9 m6.3 m2 m

Interest Paid

96 k32 k9 k35 k

Income Taxes Paid

38.7 m51.1 m57.1 m50.1 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

41.8 m64.8 m24.6 m48.7 m75.2 m28 m53.8 m80 m28.7 m

Depreciation and Amortization

10.7 m16.1 m5.7 m11.6 m17.7 m6.7 m13.7 m21.5 m1.8 m

Accounts Receivable

(2.5 m)(886 k)1.9 m1.6 m(3.5 m)2.2 m2.6 m3.1 m

Inventories

(9.5 m)(12.5 m)(7.4 m)(11.7 m)(17 m)(2.3 m)(3.8 m)(6.6 m)113 m

Accounts Payable

(821 k)(2.3 m)835 k(66 k)(2.8 m)(1.2 m)(1.7 m)(3.4 m)17 m

Cash From Operating Activities

41.6 m77.2 m34.7 m47.8 m77.9 m55 m78.1 m120 m

Purchases of PP&E

(12.2 m)(15.7 m)(7.2 m)(25.1 m)(36.6 m)(9.4 m)(20.1 m)(26.7 m)

Cash From Investing Activities

(4.8 m)(8.6 m)(43.8 m)(92.3 m)(115.1 m)(36.1 m)(46.9 m)(93.1 m)

Cash From Financing Activities

9.9 m10.8 m1.8 m3.7 m5.4 m2.1 m3.9 m5.5 m

Interest Paid

25 k32 k9 k9 k1 k2 k23 k

Income Taxes Paid

27.1 m36.4 m509 k31.9 m46 m774 k32.2 m37 m
USDY, 2017

Revenue/Employee

119.9 k

Financial Leverage

1.1 x

Globus Medical Market Value History

Globus Medical Median Salaries

Source: 27 public H-1B filings from Globus Medical

Market Position of Globus Medical

Competitors

Inogen
Health - Public
Dynatronics Corporation
Health - Public
St. Jude Medical
Health - Subsidiary
Zimmer Biomet
Health - Public
Compare competitors

Traffic Overview of Globus Medical

Globus Medical Online and Social Media Presence

Globus Medical Company Life and Culture

You may also be interested in